Financial News
All News about 4D Molecular Therapeutics Inc
![](https://cdn.benzinga.com/files/images/story/2022/11/23/image-american_eagle_outfitters.jpg?width=1200&height=800&fit=crop)
Expert Ratings for 4D Molecular Therapeutics
November 18, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/08/12/aapharma_8.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://ml.globenewswire.com/media/48db3c0d-41d9-436f-9867-c5d6c586c7a4/small/4dmt-png.png)
![](https://g.foolcdn.com/editorial/images/710004/biotech-laboratory-at-work-getty.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/11/18/logo_light__1394f4f7f29565c6b00e508c771cc6f9.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_7880.png?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For November 18, 2022
November 18, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/11/18/shutterstock_2108537360_1.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/11/17/image26.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/11/16/image41.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/11/16/image26.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/11/15/image22.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/11/15/image16.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_21424.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/11/14/logo_light__1394f4f7f29565c6b00e508c771cc6f9.png?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/48db3c0d-41d9-436f-9867-c5d6c586c7a4/small/4dmt-png.png)
![](https://cdn.benzinga.com/files/images/story/2022/11/14/image31.jpeg?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/48db3c0d-41d9-436f-9867-c5d6c586c7a4/small/4dmt-png.png)
![](https://ml.globenewswire.com/media/48db3c0d-41d9-436f-9867-c5d6c586c7a4/small/4dmt-png.png)
4D Molecular Therapeutics Reports Third Quarter 2022 Financial Results
November 09, 2022
Via GlobeNewswire
![](https://ml.globenewswire.com/media/48db3c0d-41d9-436f-9867-c5d6c586c7a4/small/4dmt-png.png)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_20113.jpeg?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/48db3c0d-41d9-436f-9867-c5d6c586c7a4/small/4dmt-png.png)
Via GlobeNewswire
![](https://cdn.benzinga.com/files/images/story/2022/09/29/screenshot_2022-09-29_at_6.12.44_pm.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/09/29/image30_0.jpeg?width=1200&height=800&fit=crop)
Why Twin Vee Powercats Is Trading Lower By Over 30%; Here Are 30 Stocks Moving Premarket
September 29, 2022
Via Benzinga
![](https://ml.globenewswire.com/media/48db3c0d-41d9-436f-9867-c5d6c586c7a4/small/4dmt-png.png)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_16636.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/08/15/image29.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/08/12/image34.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_24907.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_10337.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.